OnKure Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: OnKure Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
OnKure Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $77.6M, a 40.5% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$77.6M	-$52.7M	-40.5%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$78.7M	-$69.3M	-46.8%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$84.6M	-$14.2M	-14.4%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$107M	-$746K	-0.69%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$130M	+$7.88M	+6.44%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$148M	+$14.4M	+10.8%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$98.9M	-$45.5M	-31.5%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$108M	-$45.8M	-29.8%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$123M	-$40.4M	-24.8%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$134M	-$37.7M	-22%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$144M	+$49.1M	+51.5%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$154M	+$98.8M	+179%	Dec 31, 2021	10-K	2023-03-27
Q3 2021	$163M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$171M			Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$95.3M			Mar 31, 2021	10-Q	2021-05-20
Q4 2020	$55.2M			Dec 31, 2020	10-K	2022-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.